EverydayHealthLogo
JY

Dr. Jerome Yesavage, MD

Palo Alto, CA

45 Years of Experience
Accepting patients

Who is Dr. Yesavage, Geriatric Psychiatrist in Palo Alto, CA?

Dr. Jerome Yesavage, MD is a Geriatric Psychiatrist, who primarily practices in Palo Alto, CA. He has been practicing for over 45 years and is board certified. Dr. Yesavage completed his residency at Stanford University Med Center. Dr. Yesavage is fluent in English, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Yesavage’s office at (650) 852-3287.

Where did Dr. Yesavage go to medical school and complete their residency?

  • Residency: Stanford University Med Center

Is Dr. Yesavage board certified as a Geriatric Psychiatrist?

Yes, Dr. Jerome Yesavage, MD is board certified by the American Board of Psychiatry and Neurology

What languages does Dr. Yesavage speak?

Dr. Yesavage and their clinical team can communicate with patients in the following languages:

  • English

Does Dr. Yesavage accept my insurance?

Please contact Dr. Yesavage's office to confirm accepted insurance plans.

Where is Dr. Yesavage's office located?

Dr. Jerome Yesavage's Primary Practice

3801 Miranda Ave

Palo Alto, CA 94304

(650) 852-3287

Get Directions

What hospitals are Dr. Yesavage affiliated with?

Dr. Yesavage has admitting privileges at the following hospitals:

Palo Alto VA Medical Center,Palo Alto, CA

Recognitions

Publications

  • Intraindividual variability in basic reaction time predicts middle-aged, 2013

  • Phenotyping apathy in individuals with Alzheimer disease using functiol principal component alysis., 2013

  • Nocturia Compounds Nocturl Wakefulness in Older Individuals with Insomnia, 2013

  • Pilot Expertise and Hippocampal Size: Associations with Longitudil Flight Simulator Performance, 2012

  • Decreased Daytime Motor Activity Associated With Apathy in Alzheimer Disease: An Actigraphic Study, 2012

  • Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease, 2012

  • Brief morning light treatment for sleep, 2012

  • Sleep-Disordered Breathing in Vietm Veterans with Posttraumatic Stress Disorder, 2012

  • Phenotyping Apathy in Individuals With Alzheimer Disease Using Functiol Principal Component Alysis.

  • Delineating a Retesting Zone Using Receiver Operating Characteristic Alysis on Serial QuantiFERON, 2012

  • Effectiveness of evening phototherapy for insomnia is reduced by bright daytime light exposure, 2011

  • The Roles of COMT val158met Status and Aviation Expertise, 2011

  • Initial Cognitive Performance Predicts Longitudil Aviator Performance, 2011

  • Circadian Clock Gene Polymorphisms and Sleep-Wake Disturbance in Alzheimer Disease, 2011

  • Influences of APOE epsilon 4 and Expertise on Performance of Older Pilots, 2011

  • Faster REM sleep EEG and worse restedness in older insomniacs with HLA DQB1*0602, 2011

  • Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease, 2011

  • MR Spectroscopy for Assessment of Memantine Treatment in Mild to Moderate Alzheimer Dementia, 2011

  • Nicotine Deprivation and Pilot Performance During Simulated Flight, 2010

  • The impact of brain size on pilot performance varies with aviation training and years of education, 2010

  • Age and Expertise Effects in Aviation Decision Making and Flight Control in a Flight Simulator, 2010

  • Increasing the Ranks of Academic Researchers in Mental Health, 2010

  • Neuroprotective tural antibodies to assemblies of amyloidogenic peptides decrease with normal aging, 2009

  • Gene expression profile of the PDAPP mouse model for Alzheimer's disease with, 2009

  • Acetylcholinesterase inhibitor in combition with cognitive training in older adults, 2008

  • Donepezil treatment and Alzheimer disease, 2007

  • Should one use medications in combition with cognitive training? If so, which ones?, 2007

  • In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1, 2007

  • Pilot age and expertise predict flight simulator performance - A 3-year longitudil study, 2007

  • Coping, symptoms, and functioning outcomes of patients with posttraumatic stress disorder, 2006

  • Factors associated with psychiatric hospitalization of individuals diagnosed with dementia, 2006

  • Caution regarding the use of pilot studies to guide power calculations for study proposals, 2006

  • The brain-derived neurotrophic factor Val66Met polymorphism, 2006

  • Factors in choosing atypical antipsychotics, 2006

  • Hormone replacement therapy and longitudil cognitive performance in postmenopausal women, 2005

  • Nocturl sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon 4 carriers, 2005

  • Relating medial temporal lobe volume to frontal fMRI activation for memory encoding in older adults, 2005

  • Tolerability and effectiveness of lamotrigine in complex elderly patients, 2005

  • Cognitive ability, expertise, and age differences in following air-traffic control instructions, 2005

  • The development and initial validation of the Termilly Ill Grief or Depression Scale (TIGDS), 2005

  • Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease, 2005

  • The measurement of sleep by actigraphy, 2004

  • Validation of a 26-point telephone version of the mini-mental state examition, 2004

  • VA practice patterns and practice guidelines for treating posttraumatic stress disorder, 2004

  • Sleep/wake disruption in Alzheimer's disease: APOE status and longitudil course, 2004

  • Use of a VA pharmacy database to screen for areas at high risk for disease, 2004

  • Differential associations between entorhil and hippocampal volumes and memory performance, 2003

  • Age and disease severity predict choice of atypical neuroleptic, 2003

  • Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease, 2003

  • Psychoactive drugs and pilot performance: A comparison of nicotine, donepezil, and alcohol effects, 2003

  • Use of an exterl mnemonic to augment the efficacy of an interl mnemonic in older adults, 2003

  • Variable effects of aging on frontal lobe contributions to memory, 2002

  • Ethical, and practical issues in applying functiol imaging to the clinical magement of Alzheimer's, 2002

  • Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment, 2002

  • Interactive influences on BVRT performance level: geriatric considerations, 2002

  • Donepezil and flight simulator performance: Effects on retention of complex skills, 2002

  • Sleep/wake cycle disturbance in Alzheimer's disease: How much is due to an inherent trait?, 2002

  • How well are clinicians following dementia practice guidelines?, 2002

  • Which Alzheimer patients are at risk for rapid cognitive decline?, 2002

  • CSF hypocretin/orexin levels in rcolepsy and other neurological conditions, 2001

  • Influence of the menstrual cycle on flight simulator performance after alcohol ingestion, 2001

  • Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha-889*1 allele, 2001

  • Relationship between variations, 2001

  • One year of insulin-like growth factor I treatment does not affect bone density, body composition, 2001

  • Event-related brain potential evidence of spared knowledge in Alzheimer's disease, 2001

  • Hearing impairment and serial word recall in older adults, 2000

  • Ethanol pharmacokinetics in white women: Nonlinear model fitting versus zero-order elimition alyses, 2000

  • A retrospective chart review of gabapentin for the treatment of aggressive, 2000

  • A longitudil study of Apolipoprotein-E genotype, 2000

  • Combined assessment of tau and neurol thread protein in Alzheimer's disease CSF, 2000

  • Relationship of CogScreen-AE to flight simulator performance and pilot age, 2000

  • An actigraphic comparison of sleep restriction, 2000

  • Update on Alzheimer's disease: recent findings and treatments, 2000

  • How can we learn about developmental processes from cross-sectiol studies, or can we?, 2000

  • Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's disease, 2000

  • Convergent behavioral and neuropsychological evidence, 1999

  • Dissociation between two forms of conceptual priming in Alzheimer's disease, 1999

  • Brain structural and cognitive correlates of clock drawing performance in Alzheimer's disease, 1999

  • Predicting response of older adults to mnemonic training: who will benefit?, 1999

  • Relationship of age and simulated flight performance, 1999

  • Mnemonic training in older adults: effects of age, length of training, 1999

  • How to drastically reduce priming in word stem completion and still present the words, 1999

  • Geriatric performance on the Benton visual retention test, 1999

  • Effects of menstrual cycle and female sex steroids on ethanol pharmacokinetics, 1999

  • Gender differences in moderate drinking effects, 1999

  • The APOE epsilon 4 allele is associated with decline on delayed recall performance in community, 1998

  • The stages of Alzheimer's disease: A reappraisal, 1998

  • Influence of nicotine on simulator flight performance in non smokers, 1998

  • Preserved priming across study-test picture transformations in patients with Alzheimer's disease, 1998

  • Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease, 1998

  • A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients, 1998

  • Adjusting Mini-Mental State Examition scores for age and educatiol level to screen for dementia, 1998

  • Structural MRI correlates of recognition memory in Alzheimer's disease, 1998

  • Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer, 1997

  • No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease, 1997

  • No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease, 1997

  • Automatic and effortful processing in aging and dementia: Event-related brain potentials, 1997

  • The apolipoprotein E epsilon 4 allele is associated with increased behavioral disturbance, 1997

  • Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1, 1996

  • PERCEPTIONS OF LIFE STRESS AND CHRONIC INSOMNIA IN OLDER ADULTS, 1995

  • LONGITUDIL VOLUMETRIC COMPUTED TOMOGRAPHIC ALYSIS OF REGIOL BRAIN CHANGES, 1995

  • IDENTIFICATION OF FAST AND SLOW DECLINERS IN ALZHEIMER-DISEASE - A DIFFERENT APPROACH, 1995

  • FLIGHT SIMULATOR PERFORMANCE OF YOUNGER AND OLDER AIRCRAFT PILOTS - EFFECTS OF AGE AND ALCOHOL, 1994

  • HOW FAR VS HOW FAST IN ALZHEIMERS-DISEASE - THE QUESTION REVISITED, 1994

  • Spontaneous mnemonic strategies used by older and younger adults to remember proper mes., 1993

  • Cognitive decline in Alzheimer's disease, 1993

  • THE TIME-COURSE OF ALCOHOL IMPAIRMENT OF GENERAL, 1993

  • DEPRESSION AS A CONFOUNDING VARIABLE IN THE ESTIMATION OF HABITUAL SLEEP TIME, 1993

  • THE METHODOLOGY OF STUDYING DECLINE IN ALZHEIMERS-DISEASE, 1993

  • Differential diagnosis between depression and dementia., 1993

  • DEVELOPMENT OF APHASIA, APRAXIA, AND AGNOSIA AND DECLINE IN ALZHEIMERS-DISEASE, 1993

  • GREATER ABNORMALITIES OF BRAIN CEREBROSPIL, 1993

  • A study of the problems older adults encounter when using a mnemonic technique., 1993

  • USE OF THE WRIST ACTIGRAPH TO STUDY INSOMNIA IN OLDER ADULTS, 1993

  • INFLUENCE OF AGING AND PRACTICE ON PILOTING TASKS, 1993

  • TIMING OF SLEEP AND WAKEFULNESS IN ALZHEIMERS-DISEASE PATIENTS RESIDING AT HOME, 1992

  • DEPRESSION IN THE ELDERLY - HOW TO RECOGNIZE MASKED SYMPTOMS AND CHOOSE APPROPRIATE THERAPY, 1992

  • NUTRITIOL INTAKE IN PATIENTS WITH SENILE DEMENTIA OF THE ALZHEIMER TYPE, 1991

  • BLOOD-GLUCOSE AND INSULIN-RESPONSE IN PATIENTS WITH SENILE DEMENTIA OF THE ALZHEIMERS TYPE, 1991

  • MARIJUA CARRY-OVER EFFECTS ON AIRCRAFT PILOT PERFORMANCE, 1991

  • ALCOHOL, AGE, AND PILOTING - JUDGMENT, MOOD, AND ACTUAL PERFORMANCE, 1991

  • A PRELIMIRY-STUDY COMPARING SLEEP RESTRICTION AND RELAXATION TREATMENTS FOR INSOMNIA IN OLDER, 1991

  • Cognitive decline in patients with Alzheimer disease, 1991

  • THE INFLUENCE OF ALCOHOL AND AGING ON RADIO-COMMUNICATION DURING FLIGHT, 1990

  • MARIJUA, AGING, AND TASK-DIFFICULTY EFFECTS ON PILOT PERFORMANCE, 1989

  • SLEEP-APNEA IN ALZHEIMERS-DISEASE, 1989

  • REM LATENCY IN ALZHEIMERS-DISEASE, 1989

  • TECHNIQUES FOR COGNITIVE TRAINING OF MEMORY IN AGE-ASSOCIATED MEMORY IMPAIRMENT, 1989

  • Nonpharmacologic treatment of age-associated memory impairment., 1988

  • VALIDATION OF THE GERIATRIC PSYCHIATRY KNOWLEDGE TEST, 1988

  • TARDIVE-DYSKINESIA AND STEADY-STATE SERUM LEVELS OF THIOTHIXENE, 1987

  • IMAGERY MNEMONIC TRAINING IN A PATIENT WITH PRIMARY

What is Dr. Yesavage's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

Dr. Yesavage's National Provider Identifier (NPI) number is 1881862993.

What common questions do patients ask about Dr. Yesavage?

Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Yesavage

What is Dr. Jerome Yesavage's specialty?

What does a Geriatric Psychiatrist do?

Geriatric Psychiatry is a subspecialty focused on the prevention, assessment, diagnosis, and treatment of mental and emotional disorders in older adults. It aims to enhance psychiatric care for both healthy and ill elderly patients.

Is Dr. Jerome Yesavage affiliated with a ranked Castle Connolly Top Hospital?

No, Dr. Yesavage is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Palo Alto VA Medical Center. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

When to see a Geriatric Psychiatrist?: Guides for symptoms, conditions, and treatments

Understand your symptoms and know when it’s time to see a Geriatric Psychiatrist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

Is Dr. Jerome Yesavage accepting new patients in Palo Alto, CA?

Yes, Dr. Jerome Yesavage is accepting new patients at this time.

Does Dr. Jerome Yesavage offer online booking?

Please contact Dr. Yesavage's office at (650) 852-3287 for information about online booking, telehealth, or to schedule an appointment.

How can I make an appointment with Dr. Jerome Yesavage?

Please contact Dr. Yesavage's office at (650) 852-3287 to schedule an appointment.

Where is Dr. Yesavage's office located?

Dr. Yesavage's office is located in Palo Alto, CA.

Which board certifications does Dr. Jerome Yesavage have?

Dr. Jerome Yesavage is certified by the American Board of Psychiatry and Neurology.